A clinical trial by a Tokyo-based venture company originating from Keio University has confirmed that transplanting cardiac muscle cell clusters called cardiomyocyte spheroids created from induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback